Tubulin Post-Translational Modifications in Cardiovascular Diseases: Emerging Mechanisms and Therapeutic Modulation by Traditional Chinese Medicine
Drug Design, Development and Therapy · 2026-06 · Volume 20 · 1-26
DOI: 10.2147/dddt.s616766 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2026-06. Verfasst von Yangfan Qi und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, People's Republic of China. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Medicine, Chinese Traditional, Protein Processing, Post-Translational, Tubulin. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Cardiovascular diseases (CVDs) severely threaten human health, and microtubule dysfunction is one of the major contributing factors. Tubulin post-translational modifications (PTMs), such as detyrosination, acetylation, and polyglutamylation, regulate microtubule homeostasis, among which the upregulation of detyrosination is a key feature of cardiovascular diseases. Traditional Chinese Medicine (TCM) can alleviate cardiac pathologies by targeting these modifications. This review discusses the driving mechanisms of PTMs in relation to the pathological changes that occur in CVDs and summarizes the therapeutic effects of traditional Chinese Medicine targeting these modifications that have been identified in recent years. By systematically searching databases such as PubMed, it was found that PTMs primarily control the stability and contractility of the microtubule cytoskeleton in cardiomyocytes. Their dysregulation promotes the progression of diseases such as myocardial infarction (MI), atherosclerosis (AS), arrhythmias, and cardiac hypertrophy by disrupting key processes including mitochondrial energy metabolism, inflammasome activation, calcium homeostasis, and oxidative stress (OS). Certain active compounds found in TCM, such as curdione, evodiamine, and tanshinone IIA (Tan-IIA), can modulate PTMs through the synergistic regulation of multiple pathways. This review provides a theoretical basis for establishing TCM-based therapeutic strategies for CVDs that target PTMs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, People's Republic of China.
- Medical School, Hunan University of Chinese Medicine, Changsha, Hunan, People's Republic of China.
- Provincial Key Laboratory of TCM Diagnostics, Hunan University of Chinese Medicine, Changsha, Hunan, People's Republic of China.
Zitieren
APA
Qi, Y., Zhou, Y., Ning, X., Ye, J., Hu, Z., & Li, L. (2026). Tubulin Post-Translational Modifications in Cardiovascular Diseases: Emerging Mechanisms and Therapeutic Modulation by Traditional Chinese Medicine. Drug Design, Development and Therapy, Volume 20, 1-26. https://doi.org/10.2147/dddt.s616766
Vancouver
Qi Y, Zhou Y, Ning X, Ye J, Hu Z, Li L. Tubulin Post-Translational Modifications in Cardiovascular Diseases: Emerging Mechanisms and Therapeutic Modulation by Traditional Chinese Medicine. Drug Design, Development and Therapy. 2026;Volume 20:1-26. doi:10.2147/dddt.s616766
BibTeX
@article{Qi2026,
author = {Qi, Yangfan and Zhou, Yiyi and Ning, Xinyue and Ye, Jiahao and Hu, Zhixi and Li, Lin},
title = {Tubulin Post-Translational Modifications in Cardiovascular Diseases: Emerging Mechanisms and Therapeutic Modulation by Traditional Chinese Medicine},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--26},
doi = {10.2147/dddt.s616766}
}
EUVIMED